AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/142
EPIPHENOMENAL, CAUSAL, OR CORRELATIONAL - MORE ON THE MECHANISM(S) OFACTION OF ANTIDEPRESSANTS
Authors: SHADER RI FOGELMAN SM GREENBLATT DJ
Citation: Ri. Shader et al., EPIPHENOMENAL, CAUSAL, OR CORRELATIONAL - MORE ON THE MECHANISM(S) OFACTION OF ANTIDEPRESSANTS, Journal of clinical psychopharmacology, 18(4), 1998, pp. 265-267
APPETITE-SUPPRESSANT DRUGS AS INHIBITORS OF HUMAN CYTOCHROMES P450 - IN-VITRO INHIBITION OF P450-2D6 BY D-FENFLURAMINE AND L-FENFLURAMINE, BUT NOT PHENTERMINE
Authors: VONMOLTKE LL GREENBLATT DJ CIRAULO DA GRASSI JM GRANDA BW DUAN SX HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., APPETITE-SUPPRESSANT DRUGS AS INHIBITORS OF HUMAN CYTOCHROMES P450 - IN-VITRO INHIBITION OF P450-2D6 BY D-FENFLURAMINE AND L-FENFLURAMINE, BUT NOT PHENTERMINE, Journal of clinical psychopharmacology, 18(4), 1998, pp. 338-341
CONFLICTS-OF-INTEREST, REDUNDANT PUBLICATION, AND IDENTIFICATION OF AUTHORSHIP - A PLEA FOR TRUST INSTEAD OF SUSPICION
Authors: GREENBLATT DJ SHADER RI
Citation: Dj. Greenblatt et Ri. Shader, CONFLICTS-OF-INTEREST, REDUNDANT PUBLICATION, AND IDENTIFICATION OF AUTHORSHIP - A PLEA FOR TRUST INSTEAD OF SUSPICION, Journal of clinical psychopharmacology, 18(3), 1998, pp. 183-184
ALPRAZOLAM IS ANOTHER SUBSTRATE FOR HUMAN CYTOCHROME P450-3A ISOFORMS
Authors: VENKATAKRISHNAN K GREENBLATT DJ VONMOLTKE LL SHADER RI
Citation: K. Venkatakrishnan et al., ALPRAZOLAM IS ANOTHER SUBSTRATE FOR HUMAN CYTOCHROME P450-3A ISOFORMS, Journal of clinical psychopharmacology, 18(3), 1998, pp. 256-256
CLOZAPINE AND FLUVOXAMINE, A CURIOUS COMPLEXITY
Authors: SHADER RI GREENBLATT DJ
Citation: Ri. Shader et Dj. Greenblatt, CLOZAPINE AND FLUVOXAMINE, A CURIOUS COMPLEXITY, Journal of clinical psychopharmacology, 18(2), 1998, pp. 101-102
NEFAZODONE IN MAJOR DEPRESSION - ADJUNCTIVE BENZODIAZEPINE THERAPY AND TOLERABILITY
Authors: RICKELS K SCHWEIZER E CASE WG DEMARTINIS N GREENBLATT DJ MANDOS LA ESPANA FG
Citation: K. Rickels et al., NEFAZODONE IN MAJOR DEPRESSION - ADJUNCTIVE BENZODIAZEPINE THERAPY AND TOLERABILITY, Journal of clinical psychopharmacology, 18(2), 1998, pp. 145-153
APOE-EPSILON-4 ALLELE AND SUSCEPTIBILITY TO DRUG-INDUCED MEMORY IMPAIRMENT IN THE ELDERLY
Authors: POMARA N TUN H DEPTULA D GREENBLATT DJ
Citation: N. Pomara et al., APOE-EPSILON-4 ALLELE AND SUSCEPTIBILITY TO DRUG-INDUCED MEMORY IMPAIRMENT IN THE ELDERLY, Journal of clinical psychopharmacology, 18(2), 1998, pp. 179-181
DRUG-INTERACTIONS WITH NEWER ANTIDEPRESSANTS - ROLE OF HUMAN CYTOCHROMES P450
Authors: GREENBLATT DJ VONMOLTKE LL HARMATZ JS SHADER RI
Citation: Dj. Greenblatt et al., DRUG-INTERACTIONS WITH NEWER ANTIDEPRESSANTS - ROLE OF HUMAN CYTOCHROMES P450, The Journal of clinical psychiatry, 59, 1998, pp. 19-27
BENZODIAZEPINE USE AND CRASH RISK IN OLDER PATIENTS
Authors: POMARA N TUN H DASILVA D DEPTULA D KLINE NS GREENBLATT DJ
Citation: N. Pomara et al., BENZODIAZEPINE USE AND CRASH RISK IN OLDER PATIENTS, JAMA, the journal of the American Medical Association, 279(2), 1998, pp. 113-114
THE MATURATION OF CLINICAL-PHARMACOLOGY - RECOGNIZING THE CONTRIBUTIONS OF DR. LASAGNA,LOUIS
Authors: GREENBLATT DJ
Citation: Dj. Greenblatt, THE MATURATION OF CLINICAL-PHARMACOLOGY - RECOGNIZING THE CONTRIBUTIONS OF DR. LASAGNA,LOUIS, Journal of clinical pharmacology, 38(7), 1998, pp. 572-574
PHARMACOKINETICS AND PHARMACODYNAMICS OF DIPHENHYDRAMINE 25 MG IN YOUNG AND ELDERLY VOLUNTEERS
Authors: SCAVONE JM GREENBLATT DJ HARMATZ JS ENGELHARDT N SHADER RI
Citation: Jm. Scavone et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF DIPHENHYDRAMINE 25 MG IN YOUNG AND ELDERLY VOLUNTEERS, Journal of clinical pharmacology, 38(7), 1998, pp. 603-609
PROTEASE INHIBITORS AS INHIBITORS OF HUMAN CYTOCHROMES P450 - HIGH-RISK ASSOCIATED WITH RITONAVIR
Authors: VONMOLTKE LL GREENBLATT DJ GRASSI JM GRANDA BW DUAN SX FOGELMAN SM DAILY JP HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., PROTEASE INHIBITORS AS INHIBITORS OF HUMAN CYTOCHROMES P450 - HIGH-RISK ASSOCIATED WITH RITONAVIR, Journal of clinical pharmacology, 38(2), 1998, pp. 106-111
5 DISTINCT HUMAN CYTOCHROMES MEDIATE AMITRIPTYLINE N-DEMETHYLATION IN-VITRO - DOMINANCE OF CYP 2C19 AND 3A4
Authors: VENKATAKRISHNAN K GREENBLATT DJ VONMOLTKE LL SCHMIDER J HARMATZ JS SHADER RI
Citation: K. Venkatakrishnan et al., 5 DISTINCT HUMAN CYTOCHROMES MEDIATE AMITRIPTYLINE N-DEMETHYLATION IN-VITRO - DOMINANCE OF CYP 2C19 AND 3A4, Journal of clinical pharmacology, 38(2), 1998, pp. 112-121
SINGLE-DOSE PHARMACOKINETICS AND PHARMACODYNAMICS OF ALPRAZOLAM IN ELDERLY AND YOUNG SUBJECTS
Authors: KAPLAN GB GREENBLATT DJ EHRENBERG BL GODDARD JE HARMATZ JS SHADER RI
Citation: Gb. Kaplan et al., SINGLE-DOSE PHARMACOKINETICS AND PHARMACODYNAMICS OF ALPRAZOLAM IN ELDERLY AND YOUNG SUBJECTS, Journal of clinical pharmacology, 38(1), 1998, pp. 14-21
PHARMACOKINETICS AND ELECTROENCEPHALOGRAPHIC EFFECTS OF KETOCONAZOLE
Authors: KOTEGAWA T LAURIJSSENS BE GREENBLATT DJ
Citation: T. Kotegawa et al., PHARMACOKINETICS AND ELECTROENCEPHALOGRAPHIC EFFECTS OF KETOCONAZOLE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 35141-35141
EFFECTS OF KETOCONAZOLE ON TRIAZOLAM PHARMACOKINETICS, PHARMACODYNAMICS AND BENZODIAZEPINE RECEPTOR-BINDING IN MICE
Authors: FAHEY JM PRITCHARD GA VONMOLTKE LL PRATT JS GRASSI JM SHADER RI GREENBLATT DJ
Citation: Jm. Fahey et al., EFFECTS OF KETOCONAZOLE ON TRIAZOLAM PHARMACOKINETICS, PHARMACODYNAMICS AND BENZODIAZEPINE RECEPTOR-BINDING IN MICE, The Journal of pharmacology and experimental therapeutics, 285(1), 1998, pp. 271-276
RELATIVE QUANTITIES OF CATALYTICALLY ACTIVE CYP 2C9 AND 2C19 IN HUMANLIVER-MICROSOMES - APPLICATION OF THE RELATIVE ACTIVITY FACTOR APPROACH
Authors: VENKATAKRISHNAN K VONMOLTKE LL GREENBLATT DJ
Citation: K. Venkatakrishnan et al., RELATIVE QUANTITIES OF CATALYTICALLY ACTIVE CYP 2C9 AND 2C19 IN HUMANLIVER-MICROSOMES - APPLICATION OF THE RELATIVE ACTIVITY FACTOR APPROACH, Journal of pharmaceutical sciences, 87(7), 1998, pp. 845-853
INHIBITION OF DESIPRAMINE HYDROXYLATION (CYTOCHROME P450-2D6) IN-VITRO BY QUINIDINE AND BY VIRAL PROTEASE INHIBITORS - RELATION TO DRUG-INTERACTIONS IN-VIVO
Authors: VONMOLTKE LL GREENBLATT DJ DUAN SX DAILY JP HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., INHIBITION OF DESIPRAMINE HYDROXYLATION (CYTOCHROME P450-2D6) IN-VITRO BY QUINIDINE AND BY VIRAL PROTEASE INHIBITORS - RELATION TO DRUG-INTERACTIONS IN-VIVO, Journal of pharmaceutical sciences, 87(10), 1998, pp. 1184-1189
COMPARATIVE KINETICS AND DYNAMICS OF ZALEPLON, ZOLPIDEM, AND PLACEBO
Authors: GREENBLATT DJ HARMATZ JS VONMOLTKE LL EHRENBERG BL HARREL L CORBETT K COUNIHAN M GRAF JA DARWISH M MERTZANIS P MARTIN PT CEVALLOS WH SHADER RI
Citation: Dj. Greenblatt et al., COMPARATIVE KINETICS AND DYNAMICS OF ZALEPLON, ZOLPIDEM, AND PLACEBO, Clinical pharmacology and therapeutics, 64(5), 1998, pp. 553-561
KETOCONAZOLE INHIBITION OF TRIAZOLAM AND ALPRAZOLAM CLEARANCE - DIFFERENTIAL KINETIC AND DYNAMIC CONSEQUENCES
Authors: GREENBLATT DJ WRIGHT CE VONMOLTKE LL HARMATZ JS EHRENBERG BL HARREL LM CORBETT K COUNIHAN M TOBIAS S SHADER RI
Citation: Dj. Greenblatt et al., KETOCONAZOLE INHIBITION OF TRIAZOLAM AND ALPRAZOLAM CLEARANCE - DIFFERENTIAL KINETIC AND DYNAMIC CONSEQUENCES, Clinical pharmacology and therapeutics, 64(3), 1998, pp. 237-247
INHIBITION OF TRIAZOLAM CLEARANCE BY MACROLIDE ANTIMICROBIAL AGENTS -IN-VITRO CORRELATES AND DYNAMIC CONSEQUENCES
Authors: GREENBLATT DJ VONMOLTKE LL HARMATZ JS COUNIHAN M GRAF JA DUROL ALB MERTZANIS P DUAN SX
Citation: Dj. Greenblatt et al., INHIBITION OF TRIAZOLAM CLEARANCE BY MACROLIDE ANTIMICROBIAL AGENTS -IN-VITRO CORRELATES AND DYNAMIC CONSEQUENCES, Clinical pharmacology and therapeutics, 64(3), 1998, pp. 278-285
IMPAIRED CLEARANCE OF TRIAZOLAM BY MACROLIDE COADMINISTRATION - IN-VITRO CORRELATES AND CLINICAL CONSEQUENCES
Authors: GREENBLATT DJ VONMOLTKE LL HARMATZ JS WRIGHT CE HARREL L COUNIHAN M GRAF J MERTZANIS P SHADER RI
Citation: Dj. Greenblatt et al., IMPAIRED CLEARANCE OF TRIAZOLAM BY MACROLIDE COADMINISTRATION - IN-VITRO CORRELATES AND CLINICAL CONSEQUENCES, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 42-42
REEVALUATION OF THE SPECIFICITY OF DEXTROMETHORPHAN AS AN INDEX SUBSTRATE
Authors: VONMOLTKE LL GREENBLATT DJ GRASSI JG GRANDA BW SCHMIDER J HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., REEVALUATION OF THE SPECIFICITY OF DEXTROMETHORPHAN AS AN INDEX SUBSTRATE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 80-80
PROTEASE INHIBITORS AS INHIBITORS OF HUMAN CYTOCHROMES P450 - HIGH-RISK ASSOCIATED WITH RITONAVIR
Authors: VONMOLTKE LL GREENBLATT DJ GRASSI JG GRANDA BW DUAN SX DAILY JP HARMATZ JS SHADER RI
Citation: Ll. Vonmoltke et al., PROTEASE INHIBITORS AS INHIBITORS OF HUMAN CYTOCHROMES P450 - HIGH-RISK ASSOCIATED WITH RITONAVIR, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 81-81
PHARMACOKINETIC PHARMACODYNAMIC EVALUATION OF ALPRAZOLAM SUSTAINED-RELEASE, BROMAZEPAM (B) AND LORAZEPAM (L)/
Authors: BUSTO UE SELLERS EM KAPLAN HL WRIGHT CE GREENBLATT DJ
Citation: Ue. Busto et al., PHARMACOKINETIC PHARMACODYNAMIC EVALUATION OF ALPRAZOLAM SUSTAINED-RELEASE, BROMAZEPAM (B) AND LORAZEPAM (L)/, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 113-113
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>